Delaware Governor Signs Bill Allowing Medical Cannabis Use for Terminally Ill Patients in Hospitals
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMedical CannabisTerminally IllHospitalsHempTHCRegulation Why This Matters Delaware’s legalization of medical…
Why Averages Fail Palliative Cannabis Patients – A New Framework
Randomized controlled trials often fail to capture what palliative care cannabis patients actually experience. A new contextual effectiveness framework argues that averaging subjective outcomes obscures genuine individual benefit. This Evidence Brief…
The Limits of Averages: A Framework for Contextual Effectiveness in Palliative Care Medicinal Cannabis Research.
This article explores contextual effectiveness in palliative care cannabis research, addressing why patient-reported benefits often differ from clinical trial averages. It highlights the importance of individualized treatment outcomes in medicinal…
Pennsylvania Lawmakers Pass Bill Supporting Medical Marijuana Use in Hospitals
Pennsylvania lawmakers have approved a hospital medical marijuana policy to allow terminally ill patients to use medical cannabis in hospitals. This policy addresses care discontinuity caused by previous hospital cannabis prohibitions. The new…
Louisiana Senate Passes Bill To Let Terminally Ill Patients Use Medical Marijuana In Hospitals
Hospital cannabis policies are evolving to support terminally ill patients using medical marijuana during hospital stays. This legislation addresses critical gaps in palliative care continuity. It ensures patients maintain access to symptom management…
Study: Cannabinoid Therapy Linked to Reduced Pain and Improved Outcomes in Prostate Cancer
Cannabinoid therapy prostate cancer pain management shows promise as an adjunct or alternative to opioids. This approach may reduce pain and improve outcomes for prostate cancer patients. Evidence supports further clinical research to guide oncology care…
Amyotrophic Lateral Sclerosis (ALS) and Medical Cannabis in Utah
Utah's amyotrophic lateral sclerosis cannabis guidelines provide a state-sanctioned framework for managing ALS symptoms with medical cannabis. These guidelines influence patient access and prescribing protocols. They represent growing recognition of…
Medicinal Cannabis Shows Efficacy for Alzheimer’s Palliative Care – Sechat
Cannabis palliative care Alzheimer's offers promising symptom management for agitation, sleep disruption, and appetite loss in dementia. Emerging evidence suggests cannabinoids may address neuroinflammation and behavioral symptoms. This approach supports…
Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review.
Medical cannabis supportive care offers promising symptom management for patients with head and neck cancers. This narrative review highlights its role in alleviating pain, nausea, and cachexia. Patients affected by these cancers may benefit from…
The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
The CAN-PACT program focuses on psychedelic-assisted therapy cancer patients to address demoralization syndrome. This multi-phase initiative aims to improve supportive care for advanced cancer patients. It establishes clinical infrastructure and training…